Followers | 18 |
Posts | 634 |
Boards Moderated | 0 |
Alias Born | 05/19/2017 |
Monday, February 20, 2023 1:34:27 PM
What about this?
https://www.yahoo.com/news/covid-cause-heart-problems-heres-150000401.html
When a person is infected with Covid, the immune system launches a hefty inflammatory response in an effort to fight off the virus. That inflammation, the new study found, disrupts how calcium is stored in the heart.
Calcium ions — a version of the element that carry a positive charge — are important messengers that regulate heart function, including how quickly and how forcefully the organ contracts. These ions are stored inside cells, on deck for when the body needs to use them. They’re released through channels in the cellular membrane, which ensures that just the right amount of calcium can get out.
The damage caused by inflammation during a Covid infection appears to prop these channels open, letting too much calcium leak from the cells of the heart, said Dr. Andrew Marks, a cardiologist and biophysics professor at Columbia University who co-led the study. This flood of calcium, he said, can decrease heart function and even cause fatal arrhythmias, or irregular heartbeats.
Although inflammation of the heart is a rare but documented side effect of the mRNA Covid vaccines, the study looked only at heart tissue from autopsies before vaccines were available.
“Whatever changes we saw were because of infection,” Marks said, adding that the new study was small, and the next step was to conduct the research on a larger scale.
Calcium also plays an important role in the brain
The findings built on something Marks and his team had observed earlier in the pandemic when they were investigating how Covid affects another organ: the brain.
In a study published in 2021 in the journal Alzheimer’s and Dementia, the team found the same cellular damage to calcium ion channels in autopsied brain tissue of people who had been infected with Covid. These changes, Marks noted, had long been seen in people with Alzheimer’s disease.
Dr. Siddharth Singh, clinical director of the post-Covid-19 cardiology clinic at the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles, said the latest findings help explain the heart and brain problems seen in Covid patients.
“Calcium is an essential mineral for life,” said Singh, who was not involved with the research.
“This may put things together for the heart and the brain.”
Viral infections causing inflammation of the heart is not a new finding.
“Before Covid came onto the scene, during the winter, when viral infections would spike, we would see more people presenting with things like myocarditis,” said Singh, referring to inflammation of the heart lining.
He said the damage wasn’t necessarily permanent. “Over time, symptoms like brain fog and palpitations do get better in some patients, so to an extent, this damage appears to be able to heal,” he said, adding that patients need to be studied longer for researchers to understand exactly what factors allow this to happen.
Dr. Nicholas Hendren, a cardiologist at UT Southwestern Medical Center in Dallas, said: “Once this is better understood, we may be able to develop therapies to treat this damage and potentially a therapy to protect the heart and cardiovascular system from damage from Covid.” Hendren was also not involved in the new research.
Recent AVXL News
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
- Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:31:07 PM
- Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/07/2024 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024 • GlobeNewswire Inc. • 02/01/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 10:01:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM